Decided

No. 15-1039

Sandoz Inc. v. Amgen Inc., et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

JUDGMENT ISSUED.

Adjudged to be VACATED IN PART, REVERSED IN PART, and case REMANDED. Thomas, J., delivered the opinion for a unanimous Court. Breyer, J., filed a concurring opinion. VIDED.

Argued. For petitioner in No. 15-1039: Deanne E. Maynard, Washington, D. C.; and Anthony A. Yang, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For petitioners in 15-1195: Seth P. Waxman, Washington, D. C. VIDED.

Motion of the Acting Solicitor General for leave to participate in oral argument as amici curiae and for divided argument GRANTED. VIDED. Justice Gorsuch too no part in the consideration or decision of this motion.

Consolidated Response and Reply Brief for Sandoz Inc. Filed. (Distributed) VIDED.

Record received from the U.S.C.A. for the Federal Circuit. The record is available on PACER, except for confidential materials transmitted separately. VIDED.

CIRCULATED.

Motion of the Acting Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed. VIDED.

Brief amicus curiae of Genentech, Inc. filed. VIDED.

Brief amicus curiae of Biotechnology Innovation Organization filed. VIDED.

Brief amicus curiae of AbbeVie Inc. filed. VIDED.

Brief amicus curiae of Janssen Biotech, Inc. filed. VIDED.

Opening and Response Brief for Amgen Inc., et al. filed. VIDED.

Record requested from the U.S.C.A. for the Federal Circuit. VIDED.

Motion to dispense with printing the joint appendix filed by petitioners GRANTED. VIDED

Brief amici curiae of AARP Foundation, et al. filed.

SET FOR ARGUMENT ON Wednesday, April 26, 2017. VIDED.

Brief amicus curiae of Mylan, Inc. filed. VIDED.

Brief amicus curiae of Coherus Biosciences, Inc. filed. VIDED.

Brief amici curiae of Apotex Inc. and Apotex Corp. filed. VIDED.

Brief amicus curiae of Adello Biologics, LLC filed.

Brief amicus curiae of United States filed. VIDED.

Brief amicus curiae of America's Health Insurance Plans filed. VIDED.

Brief amicus curiae of Biosimilars Council filed. VIDED.

Brief amici curiae of Pharmaceutical Care Management Association, et al. filed.

Brief of petitioner Sandoz Inc. filed.

Joint motion of the parties to dispense with printing the joint appendix filed. VIDED.

The following briefing schedule is adopted: Petitioner in No. 15-1039 will file an opening brief limited to the question presented in its petition, not to exceed 15,000 words, on or before Friday, February 10, 2017. Petitioners in No. 15-1195 will file a consolidated opening brief on the question presented in their petition and response brief, not to exceed 19,000 words, on or before Friday, March 10, 2017. Petitioner in No. 15-1039 will file a consolidated response brief and reply brief, not to exceed 10,000 words, on or before Friday, March 31, 2017. Petitioners in No. 15-1195 will file a reply brief, not to exceed 6,000 words, on or before Friday, April 14, 2017. Any brief of an amicus curiae in support of petitioner in No. 15-1039 or in support of neither party is to be filed on or before Friday, February 17, 2017, and the brief should bear a light green cover. Any brief of an amicus curiae in support of petitioners in No. 15-1195 is to be filed on or before Friday, March 17, 2017, and the brie...

Petition GRANTED. The petition for a writ of certiorari in No. 15-1195 is granted. The cases are consolidated and a total of one hour is allotted for oral argument.

Motion for leave to file amici brief filed by Apotex, Inc., et al. GRANTED.

DISTRIBUTED for Conference of January 13, 2017.

DISTRIBUTED for Conference of January 6, 2017.

Supplemental brief of respondents Amgen Inc., et al. filed. VIDED.

Brief amicus curiae of United States filed. VIDED.

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

Reply of petitioner Sandoz Inc. filed. (Distributed)

DISTRIBUTED for Conference of June 16, 2016.

Brief amicus curiae of Mylan, Inc. filed.

Brief of respondents Amgen Inc., et al. in opposition filed.

Brief amici curiae of Hospira, Inc, et al. filed.

Motion for leave to file amici brief filed by Apotex, Inc., et al.

Brief amicus curiae of Biosimilars Council filed.

Petition for a writ of certiorari filed. (Response due March 21, 2016)

Application (15A672) granted by The Chief Justice extending the time to file until February 16, 2016.

Application (15A672) to extend the time to file a petition for a writ of certiorari from January 14, 2016 to February 16, 2016, submitted to The Chief Justice.

Parties

Sandoz Inc., Petitioner, represented by Deanne E. Maynard

Amgen Inc., et al., Respondent, represented by Seth P. Waxman

Amgen Inc., et al., Respondent, represented by Nicholas Groombridge

Amici Curiae

AARP Foundation, et al., Amicus Curiae, represented by William Alvarado Rivera

AbbVie Inc. ., Amicus Curiae, represented by Melissa Arbus Sherry

Adello Biologics,LLC, Amicus Curiae, represented by Clifton S. Elgarten

America's Health Insurance Plans, Amicus Curiae, represented by Carlos T. Angulo

Apotex Inc. and Apotex Corp., Amicus Curiae, represented by David C. Frederick

Biosimilars Council, Amicus Curiae, represented by William M. Jay

Biotechnology Innovation Organization, Amicus Curiae, represented by Donald R. Ware

Coherus Biosciences, Inc., Amicus Curiae, represented by Craig E. Countryman

Genentech, Inc., Amicus Curiae, represented by E. Joshua Rosenkranz

Hospira, Inc, et al., Amicus Curiae, represented by Charles B. Klein

Janssen Biotech, Inc., Amicus Curiae, represented by Gregory L. Diskant

Mylan, Inc., Amicus Curiae, represented by William A. Rakoczy

Pharmaceutical Care Management Association, et al., Amicus Curiae, represented by James P. Ellison

United States, Amicus Curiae, represented by Anthony Alan Yang

United States, Amicus Curiae, represented by Jeffrey B. Wall

 
Last updated: October 23, 2017